PF-07265807
- Generic Name
- PF-07265807
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Phase 1
Active, not recruiting
- Conditions
- Neoplasm Metastasis
- Interventions
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 67
- Registration Number
- NCT04458259
- Locations
- 🇺🇸
Community Health Network Cancer Center North, Indianapolis, Indiana, United States
🇺🇸Community Health Network Investigational Drug Services, Indianapolis, Indiana, United States
🇺🇸Rocky Mountain Lions Eye Institute (RMLEI), Aurora, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath